T Cell Receptor Immunotherapy Targeting MAGE-A3 for Patients With Metastatic Cancer Who Are HLA-A*01 Positive
Condition(s):Breast Cancer; Cervical Cancer; Renal Cancer; Melanoma; Bladder CancerLast Updated:June 17, 2019Terminated
Hide Studies Not Open or Pending
Condition(s):Breast Cancer; Cervical Cancer; Renal Cancer; Melanoma; Bladder CancerLast Updated:June 17, 2019Terminated
Condition(s):Metastatic HPV-16 Positive Squamous Cell Anal CancerLast Updated:February 1, 2021Withdrawn
Condition(s):Juvenile Myelomonocytic Leukemia; Recurrent Acute Biphenotypic Leukemia; Recurrent Acute Undifferentiated Leukemia; Recurrent Childhood Acute Lymphoblastic Leukemia; Recurrent Childhood Acute Myeloid Leukemia; Refractory Acute Lymphoblastic Leukemia; Refractory Adult Acute Lymphoblastic Leukemia; Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive; Recurrent Blastic Plasmacytoid Dendritic Cell Neoplasm; Recurrent Myelodysplastic Syndrome; Refractory Blastic Plasmacytoid Dendritic Cell Neoplasm; Refractory Myelodysplastic Syndrome; Acute Undifferentiated Leukemia; Mixed Phenotype Acute Leukemia; Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive; Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive; Recurrent Acute Lymphoblastic Leukemia; Recurrent Acute Myeloid Leukemia; Myelodysplastic Syndrome; Acute Myeloid Leukemia; Acute Lymphoblastic Leukemia; Acute Biphenotypic Leukemia; Chronic Myeloid Leukemia; Chronic Myelomonocytic Leukemia; Minimal Residual Disease; Recurrent Chronic Myelomonocytic Leukemia; Recurrent Mixed Phenotype Acute Leukemia; LeukemiaLast Updated:March 21, 2024Suspended
Condition(s):COVID-19Last Updated:June 13, 2022Completed
Condition(s):Prostatic Neoplasms; Neoplasms of Prostate; Prostate Cancer; Cancer Of Prostate; Stage D0 Prostate CancerLast Updated:February 28, 2024Completed
Condition(s):Bone Sarcoma; Soft Tissue SarcomaLast Updated:April 12, 2023Active, not recruiting
Condition(s):Solid TumorLast Updated:August 25, 2023Terminated
Condition(s):Synovial SarcomaLast Updated:December 6, 2023Completed
Condition(s):Pancreatic Ductal Adenocarcinoma; Non-Small Cell Lung Cancer; Colorectal Cancer; Solid Tumor; KRAS G12VLast Updated:March 13, 2024Recruiting
Condition(s):Advanced Solid Tumors; Genital Neoplasm, Female; Urogenital Neoplasms; Lung Neoplasm; Neoplasms by Site; Papillomavirus Infection; Epstein-Barr Virus Infections; Carcinoma; Neoplasms; Vulvar Neoplasms; Vulvar Diseases; Abdominal NeoplasmLast Updated:September 22, 2023Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.